文献速递血管炎

超声晕征可作为巨细胞动脉炎患者的潜在监测工具:一项前瞻性分析

Ultrasound halo sign as a potential monitoring tool for patients with giant cell arteritis: a prospective analysis.
PubMed 文献 · Ann Rheum Dis · 2021-07-02

这项前瞻性研究纳入49例超声确诊的巨细胞动脉炎(GCA)患者,在固定时间点重复评估颞动脉和腋动脉的晕征特征。结果显示颞动脉晕征特征对变化敏感,且与红细胞沉降率、C反应蛋白、BVAS及糖皮质激素累积剂量相关;首次复发时94%存在晕征但程度低于起病时。

要点

  • 颞动脉晕征数量及最大内中膜厚度与炎症指标和GC累积剂量相关
  • 腋动脉晕征特征仅在6周后才显示出对变化敏感
  • 首次复发时94%存在晕征,但晕征范围和厚度低于起病时

核心结论

  • 超声是评估GCA疾病活动度和治疗反应的有用影像工具。

研究设计与样本

  • 前瞻性研究纳入49例超声确诊的GCA患者,在固定时间点重复评估颞动脉和腋动脉,共354次访视。

主要发现

  • 颞动脉晕征特征在第1、3、6、12和24周均显示与基线相比有显著标准化均数差,腋动脉晕征特征仅在第6周后显著。
  • 颞动脉晕征段数、晕征内中膜厚度总和及最大值与ESR(0.41、0.44、0.48)、CRP(0.34、0.39、0.41)、BVAS(0.29、0.36、0.35)及GC累积剂量(-0.34、-0.37、-0.32)显著相关,腋动脉晕征特征无显著相关。
  • 首次复发时94%存在晕征,但晕征段数均值(2.93±1.59 mm vs 4.85±1.51 mm,p=0.0012)和晕征IMT总和(2.01±1.13 mm vs 4.49±1.95 mm,p=0.0012)低于起病时。

临床怎么用

  • 可将颞动脉超声晕征特征用于GCA疾病活动度和治疗反应的动态监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess the sensitivity to change of ultrasound halo features and their association with disease activity and glucocorticoid (GC) treatment in patients with newly diagnosed giant cell arteritis (GCA). METHODS: Prospective study of patients with ultrasound-confirmed GCA who underwent serial ultrasound assessments of the temporal artery (TA) and axillary artery (AX) at fixed time points. The number of segments with halo and maximum halo intima-media thickness (IMT) was recorded. Time points in which >80% of patients were assessed were considered for analysis. Halo features at disease presentation and first relapse were compared. RESULTS: 49 patients were assessed at 354 visits. Halo sensitivity to change was assessed at weeks 1, 3, 6, 12 and 24 and showed a significant standardised mean difference between all time points and baseline for the TA halo features but only after week 6 for the AX halo features. The number of TA segments with halo and sum and maximum TA halo IMT showed a significant correlation with erythrocyte sedimentation rate (0.41, 0.44 and 0.48), C reactive protein (0.34, 0.39 and 0.41), Birmingham Vasculitis Activity Score (0.29, 0.36 and 0.35) and GC cumulative dose (-0.34, -0.37 and -0.32); no significant correlation was found for the AX halo features. Halo sign was present in 94% of first disease relapses but with a lower mean number of segments with halo and sum of halo IMT compared with disease onset (2.93±1.59 mm vs 4.85±1.51 mm, p=0.0012; 2.01±1.13 mm vs 4.49±1.95 mm, p=0.0012). CONCLUSIONS: Ultrasound is a useful imaging tool to assess disease activity and response to treatment in patients with GCA.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Ponte C, Monti S, Scirè CA, et al. Ultrasound halo sign as a potential monitoring tool for patients with giant cell arteritis: a prospective analysis. Ann Rheum Dis. 2021. PMID: 34215646. doi:10.1136/annrheumdis-2021-220306

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。